PCN120 COST-UTILITY OF DOCETAXEL COMPARED WITH BEST SUPPORTIVE CARE AND PEMETREXED IN SECOND LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN POLAND
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74371-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)74371-0/fulltext
Title :
PCN120 COST-UTILITY OF DOCETAXEL COMPARED WITH BEST SUPPORTIVE CARE AND PEMETREXED IN SECOND LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN POLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74371-0&doi=10.1016/S1098-3015(10)74371-0
First page :
Section Title :
Open access? :
No
Section Order :
298